Funding for this research was provided by:
National Natural Science Foundation of China (81872063, 81872063, 81872063, 81872063)
Beijing-Tianjin-Hebei Basic Research Cooperation Project
Received: 19 July 2021
Revised: 20 November 2021
Accepted: 2 December 2021
First Online: 6 January 2022
: The authors declare no competing interests.
: For human glioma samples, written informed consent was obtained from all donors and their relatives. The study was carried out in accordance with the principles of the Helsinki Declaration and approved by the ethical committee at Tianjin Medical University General Hospital (March 03, 2018).